You are encouraged to report negative side effects of prescription products: Contact FDA MedWatch at 1-800-FDA-1088 or visit www.fda.gov/medwatch Tirzepatide administration
If symptoms are persistent, severe, or linked with other warning signs, a clinician should review your treatment to ensure it remains safe
Both medications share similar gastrointestinal side effects, such as nausea and diarrhea
This may increase your risk of side effects, such as muscle pain or damage
While both use U-100 insulin syringes for administration, they must be drawn and injected separately
BPC-157, often referred to as Body Protection Compound-157 , is a synthetic peptide derived from a protective protein found in gastric juice